Docteur Etienne HUVELLE Urgentiste SMA
|
|
|
- Arthur Cain
- 9 years ago
- Views:
Transcription
1 Docteur Etienne HUVELLE Urgentiste SMA Diplômes Diplôme de Docteur en médecine, chirurgie et accouchements Ulg Diplôme d'ingénieur civil électricien option Ingéniérie Bimédicale Traitement de signal, Ulg, Diplômes complémentaires Certificat délectrocardiographie, Ulg, 1986 Certificat Advanced Life Support (ALS) European Resuscitation Concil (ERC), ULB, Certificat Ateliers de réanimation adulte en médecine d'urgence (ARAMU), ULB, 2007 Certificat BMA (Brevet médecine aiguë), ULB, Certificat d'enseignement du PREP (Programme rapide d'échographie du polytraumatisé), CHRN, Namur, 2007 ARAMU Sutures 2008 FORMAC 1, 2010 Publications HUVELLE E., FAY R., ALLA F., SOLAL A-C., MEBAZAA A., ZANNAD F. Left bundle branch block and mortality in patients with acute heart failure syndrome : a substudy of the EFICA cohort. Eur J Heart Fail ; 12 (2) : ZANNAD F., HUVELLE E., DICKSTEIN K., VAN VELDHUISEN D-J, STELLBRINK C., KOBER L., CAZEAU S., RITTER P., MAGGIONI A-P., FERRARI R., LECHAT P. Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Fail ; 9 (1) : AURICCHIO A., STELLBRINK C., BUTTER C., SACK S., VOGT J., MISIER A-R., BOCKER D., BLOCK M., KIRKELS J-H., KRAMER A., HUVELLE E. Pacing therapies in congestive heart failure II study group ; guidant heart failure research group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacin in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll cardiol ; 42 (12) : FENELON G., STAMBLER B-S., HUVELLE E., BRUGADA P., STEVENSON W-G. European VENTAK MINI investigator group. Left ventricular dysfunction in associated with prolonged average ventricular fibrillation cycle length in patients with implantale cardioverter defibrilaltors. J Interv Card Electrophysiol ; 7 (3) :
2 BREITHARDT O-A., STELLBRINK C., KRAMER A-P., SINHA A-M., FRANCKE A., SALO R., SCHIFFGENS B., HUVELLE E., AURICCHIO A. PATH-CHF study group. Pacing therapies for congestive heart failure. Echocardiographic quantification fo left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardio ; 40 (3( : BUTTER C., AURICCHIO A., STELLBRINK C., FLECK E., DING J., YU Y., HUVELLE E., SPINELLI J. Pacing therapy for chronic heart failure II study group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001 ; 104 (25) : BUTTER C., AURICCHIO A., STELLBRINK C., SCHLEGL M., FLECK E., HORSCH W., HUVELLE E., DING J., KRAMER A. Should stimulation site be tailored in the individual heart failure patient? Am J Cardiol ; 86 (9 supl 1) : K 144-K151. BREITHARDT O-A., STELLBRINK C., FRANCKE A., AURICCHIO A., HUVELLE E., SACK S., BAKKER P., HANRATH P. Echocardiographic evidence of hemodynamic and clinical improvement in patients paced for heart failure. Am J Cardiol ; 86 (9 supll 1) : K133-K137. FENELON G., HUVELLE E., BRUGADA P. Initial clinical experience with a new small siezd third-generation implantable cardioverter defibrillator : results of a multicenter study. PACE 1997 ; 20 (12 Pt I) : KLEIN H., HUVELLE E., NISAM S. Initial clinical experience with a nex down-sized implantable cardioverter defibrillator. Am J Cardiol 1996 ; 78 (supll 5A) : Abstracts HUVELLE E., FAY R., ALLA F., SOLAL A-C., MEBAZAA A., ZANNAD F. Left bundle branch block and mortality in patients with acuter heart failure syndrome : a substudy of the EFICA cohort. HFA of the ESC (poster presentation. BUTTER C., STELLBRINK C., SCHLEGL M., SINHA A-M., CUESTA F., HUVELLE E., VILLALTA D-L., REISTER C. Hemodynamics. NASPE 2004 (poster prestentation). AURICCHIO A., GELLER C., KLOSS M., KLEIN H-U., CAZARES S., YU Y., DOELGER A., HUVELLE E. Effect of right ventricular pacing site on hemodynamic function during bi-ventricular pacing for heart failure patients with atrial fibrillation after atrioventricular node ablation. NASPE 2004 (oral presentation).
3 BUTTER C., STELLBRINK C., SACK S., VOGT J., RAMDAT-MISIER A., BOCKER D., BLOCK M., KIRKELS H., HUVELLE E., KRAMER A., POCHET T. Cardiac resynchronization therapy stratified by QRS duration : PATH-CHF-II results at one year. NASPE 2003 (oral presentation). AURICCHIO A., STELLBRINK C., BUTTER C., SACK S., VOGT J., RAMDAT-MISIER A., BOCKER D., BLOCK M., KIRKELS H., HUVELLE E., KRAMER A., POCHET T. Clinical efficacy of cardia resynchronization therapy in heart failure patients stratified by a severity of ventricular conduction delay : results of the PATH-CHF-II trial. NASPE 2002 Late breaking trial session (oral presentation). STELLBRINK C., AURICCHIO A., BUTTER C., KIRKELS H., KLOSS M., VOGT J., KRAMER A., SPINELLI J., HUVELLE E., DING J., CUESTA F. Acute hemodynamic improvement predicts chronic bnefit in heart failure patients treated with cardiac resynchronization. NASPE 2002 (oral presentation) DI PEDE F., GASPARINI G., RAVIELE A., PASTORE J., YU Y., CUESTA F., HUVELLE E. Effect of atrial stimulation site on the contractile function of heart failure patients with DDD biventricular pacing. NASPE 2002 (poster prestentation) BUTTER C., AURICCHIO A., STELLBRINK C., DING J., DOELGER A., HUVELLE E., SPINELLI J., LONGER L-V. RV delay may not yield better BiVRT outcomme in HF patients. Abstract#649. Eurospace July 2001, 2 (Supll B) : B11; SACK S., AURICCHIO A., STELLBRINK C., BOCKER D., VOGT J., BAKKER P., CUESTA P., HOERSCH W. HUVELLE E., SPINELLI J. Long-term functional capacity improvement in the PATH-CHF study. Abstract 586, Eurospace July 2001 ; 2 (Supll B) : B48. BREITHARDT O-A., KRAMER A., SALO R., SINHA A-M., HUVELLE E., AURICCHIO A., HANRATH P., SPINELLI J., STELLBRINK C. Predictive value of echocardiographic left ventricular contraction patterns in cardiac resynchronization therapy. Abstract 792, PACE April 2001 ; 24 (4, PartII) : 736 (NASPE 2001, poster presentation) BUTTER C., AURICCHIO A., STELLBRINK C., DING J., DOELGER A., HUVELLE E., SPINELLI J. Biventricular resynchronization therapy for heart failure patients : does longer RV-LV conduction delay always yield better hemodynamic responses? Abstract 61, PACE April 2001 ; 24 (4, Part II) : 629 (NASPE 2001 poster presentation). YU Y., AURICCHIO A., DING J., KRAMER A., HUVELLE E., POTTY P., SPINELLI J. Resynchronization between left and right ventricles responsible for improving hemodynamic function of heart failure patients with LBBB? Abstract 148, PACE April 2000 ; 23 (4, Part II) : 589. SACK S., AURICCHIO A., KADHISERAN V., SALO R., HUVELLE E., MICHEL U., SPINELLI J. Long term improvement with ventricular resynchronization therapy in heart failure patients : does etiology of heart failure matter? Abstract 10, PACE April 2000; 23 (4, Part II): 555.
4 YU Y., AURICCHIO A., DING J., KRAMER A., HOERSCH W., HUVELLE E., SPINELLI J. Identification of patiens suitable for ventricular resynchronization therapy based on normalized LV-RV pressure loop area. Abstract 9, PACE April 2000 ; 23 (4, Part II) : 555. FENELON G., HUVELLE E., BRUGADA P., STEVENSON W-G., STAMBLER B-S. Ventricular refractoriness is prolongated in human heart failure : analysis of the ventricular fibrillation intervals form implantable cardioverter defibrillators. Abstract 1870, Ciruclation (Supp) November 1997 ; 96 (8) (oral presentation) FENELON G., HUVELLE E., BRUGADA P. Initial clinical experience with a new small sized third-generation implantable cardioverter defibrillators : results of a multicenter study. Abstract 1970, Ciruclation (Supp) October 1996 ; 94 (8) (oral presentation). MORTENSEN P., KIRSTEIN-PEDERSEN A., HUVELLE E. Pectoral implantation of the new VENTAK MINI AICD Pulse generator. Abstract 1158, Eur. J.C.P.E. June 1996 ; + (I, Supp5) (Poster session). AURICCHIO A., KLEIN H., HUVELLE E., VOSHAGE STAHN L. Initial experience with the new VENTAK MINI HC/ENDOTAK DSP triad implantable cardioverter defibrillator system. Abstract 1080, EUR.J.C.P.E. June 1996 ; 6 (1, Supp5) (oral presentation). BRUGADA P., HUVELLE E. Initial experience with the nex VENTAK MINI AICD pulse generator. Abstract 1157, EUR.J.C.P.E. June 1996 ; 6 (1, Supp5) (Poster session). AURICCHIO A., KLEIN H., HUVELLE E., VOSHAGE STAHN L. Initial experience with the new VENTAK MINI HC/ENDOTAK DSP triad implantable cardioverter defibrillator system. Abstract 5, PACE, April 1996 ; 19 (4,Part II) (oral presentation). WILLEMS R., FERNANDEZ E., HUVELLE E., MITCHELL M. Clinical application of an endocardial lead system in ICD implantations. Abstract 242, PACE May 1993 ; 16 (5, Part II) (oral presentation). Communication orale Invité à Cardiostim 2004, samedi 19 juin : session 256 (future indications for CRT : which patients might benefit?), 2ème présentation (Patients with LBBB, Normal EF, with ventricular dyssynchrony?) Communication poster Heart failure 2099, lundi 1er juin : session clinical poster III (Acute heart failure), Poster 749 (left bundle branch block and mortality in patients with acute heart failure syndrome : a substudy of the EFICA cohort). Brevets US Patent #7,041,061 : KRAMER A., HUVELLE E. Quantification of cardiac wall motion asynchrony. May, 9, 2006.
5 US Patent #6,522,914 : HUVELLE E., CUESTA P. Method and appartuses for monitoring hemdynamic activities using an intracardiac impedance-derived parameter. Feb 18, 2003 Conférences
Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex
Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex Johannes Holzmeister, M.D. University of Zurich, Zurich, Switzerland on behalf
Updated Cardiac Resynchronization Therapy Guidelines
The Ohio State University Heart and Vascular Center Updated Cardiac Resynchronization Therapy Guidelines William T. Abraham, MD, FACP, FACC, FAHA, FESC Professor of Medicine, Physiology, and Cell Biology
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
How should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN
Basics of Pacing Ruth Hickling, RN-BSN Tasha Conley, RN-BSN The Cardiac Conduction System Cardiac Conduction System Review Normal Conduction Conduction QRS QRS Complex Complex RR PP ST ST segment segment
Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center
Introduction to Electrophysiology Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Objectives Indications for EP Study How do we do the study Normal recordings Abnormal Recordings Limitations
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
CCAD Training Manual. Cardiac Rhythm Management (CRM)
CCAD Training Manual Cardiac Rhythm Management (CRM) Version 1.0 A D Cunningham 19/3/2008 Introduction This manual is intended to assist users of the Notes Client version of the CCAD Cardiac Rhythm Management
Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure
Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure Gaetano M. De Ferrari, MD Dept. of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy for the CardioFit
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services NEW product from the Medicare Learning Network (MLN) Provider Compliance Tips for Computed Tomography (CT) Scans Podcast,
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
STANDARDS FOR IMPLANTATION AND FOLLOW-UP OF CARDIAC RHYTHM MANAGEMENT DEVICES IN ADULTS January 2013
1. INTRODUCTION STANDARDS FOR IMPLANTATION AND FOLLOW-UP OF CARDIAC RHYTHM MANAGEMENT DEVICES IN ADULTS January 2013 This document replaces the previous Heart Rhythm UK documents Clinical Guidance by Consensus
Section Four: Pulmonary Artery Waveform Interpretation
Section Four: Pulmonary Artery Waveform Interpretation All hemodynamic pressures and waveforms are generated by pressure changes in the heart caused by myocardial contraction (systole) and relaxation/filling
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs
Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population Carel Jan Willem Borleffs The studies described in this thesis were performed at the Department
Pacemaker Counter and Histogram Operation and Interpretation. Percentage of total count. Figure 2. Detailed ALTRUA Paced and Sensed Event Counters
A Closer Look SUMMARY This article provides information regarding the operation and interpretation of Event Counters and Histograms available in ALTRUA, INSIGNIA, PULSAR MAX II, and DISCOVERY II pacemakers.
Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
Heart Rhythm UK. Standards for Implantation and Follow-up of Cardiac Rhythm Management Devices HRUK, February 2011
Heart Rhythm UK Standards for Implantation and Follow-up of Cardiac Rhythm Management Devices HRUK, February 2011 1) Introduction 2) Definitions 3) Treatment indications 4) Requirements for performing
How do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
LEFT VENTRICULAR LEAD PLACEMENT IN THE LATEST ACTIVATED REGION GUIDED BY CORONARY VENOUS ELECTROANATOMIC MAPPING
LEFT VENTRICULAR LEAD PLACEMENT IN THE LATEST ACTIVATED REGION GUIDED BY CORONARY VENOUS ELECTROANATOMIC MAPPING Dott. Massimiliano Maines C. Angheben, D.Catanzariti, I.DiMatteo, A.Cima, M. Del Greco Venice,
Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
Treatment of cardiogenic shock
ACUTE HEART FAILURE AND COMORBIDITY IN THE ELDERLY Treatment of cardiogenic shock Christian J. Wiedermann, M.D., F.A.C.P. Associate Professor of Internal Medicine, Medical University of Innsbruck, Austria
Technology Assessment
Technology Assessment Use of Cardiac Resynchronization Therapy in the Medicare Population Technology Assessment Program Prepared for: Agency for Healthcare Research and Quality 540 Gaither Road Rockville,
Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE
Rome, Italy December 4-7, 2012 Rome Cavalieri Monday, December 3 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP)
Reimbursement Information For Electrophysiology and Arrhythmia Service Procedures 1
GE Healthcare Information For Electrophysiology and Arrhythmia Procedures 1 2011 Update www.gehealthcare.com/reimbursement This overview addresses coding, coverage, and payment for electrophysiology procedures
2013 Medicare Physician Coding and Reimbursement Changes
2013 Medicare Physician Coding and Reimbursement Changes Disclaimer This presentation is intended for educational use. Any duplication is prohibited without written consent of Medtronic s Economic Strategies
Management of Symptomatic Atrial Fibrillation
Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015
CURRICULUM VITAE Prof. ANTONIO CURNIS
CURRICULUM VITAE Prof. ANTONIO CURNIS I. Personal Informations - Born in February 11 th 1958 in Bergamo (Italy). - Graduated by University of Brescia 23.10.88 - Division of Cardiology of Civil Hospital
A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation
A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation Gabriel Sayer Lay Abstract: Atrial fibrillation is a common form of irregular,
Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
Device Therapy: the future is now.
Device Therapy: the future is now. Mariell Jessup MD FAHA, FACC, FESC Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania, USA Disclosure: Mariell Jessup MD University of Pennsylvania
Le complicanze nei portatori di ICD e CRT
Le complicanze nei portatori di ICD e CRT Attilio Del Rosso Key points: 1 ICD therapy has been shown to be effective in aborting sudden arrhtymic death and reducing mortality 2 Patients who do not benefit
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians May 19, 2015 Disclaimer This presentation is intended for educational use. Any duplication is prohibited without written consent
UCSF Anesthesia Resident Pearls: Cardiac Implantable Electronic Devices: Pacemakers and ICDs Table of Contents
UCSF Anesthesia Resident Pearls: Cardiac Implantable Electronic Devices: Pacemakers and ICDs Table of Contents Page 1 Intro Indications for Pacers and ICDs Page 2 Differentiating between Pacers and ICDs
Disclosures. Anesthesia and Lead Extractions. Lead Extractions: Objectives. Lead Removal Techniques. None
Anesthesia and Lead Extractions Disclosures None Bryan Ahlgren DO Assistant Professor University of Colorado Dept of Anesthesiology Objectives Define lead extraction procedures and why Anesthesiologists
Innovation Platform: Sudden Cardiac Death
Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration
2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?
2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? Gaetano Senatore DIVISION OF CARDIOLOGY HOSPITAL OF CIRIE
GuidePoint. Physician Reimbursement Primer for Cardiac Rhythm Management. With Clinical Case Examples. GuidePoint is simplifying reimbursement.
GuidePoint GuidePoint is simplifying reimbursement. Physician Reimbursement Primer for Cardiac Rhythm Management With Clinical Case Examples DISCLAIMER Reimbursement information provided by Boston Scientific
How To Improve Health Care For Remote Workers
CRM Devices and Telemonitoring Where the industry stands today Annette Brüls VP CRDM Marketing CareLink Status worldwide More than 450.000000 patients in > 4000 clinics > 30 countries 9 years of experience
Cardiogenic shock: invasive and non-invasive monitoring John T. Parissis Attikon University Hospital Athens, Greece
Cardiogenic shock: invasive and non-invasive monitoring John T. Parissis Attikon University Hospital Athens, Greece Disclosures: Research grants by Abbott USA and Orion-Pharma as a member of steering committee
Pacers use a 5-letter code: first 3 letters most important
PACEMAKERS 2 Pacemakers: Nomenclature Pacers use a 5-letter code: first 3 letters most important t First Letter: Chamber Paced A= Atrium V= Ventricle D= Dual (A+V) 2nd Letter: Chamber Sensed A= Atrium
Recurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
Atrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
Michael Hartman, CRNA, DNP, MSN, BSN, BA
Michael Hartman, CRNA, DNP, MSN, BSN, BA Intrinsic Conduction Automaticity-cardiac cells ability to spontaneously depolarize and initiate impulse Depolarization-cardiac cells go to a+ intracellular and
What Are Arrhythmias?
What Are Arrhythmias? Many people have questions about what the word arrhythmia means, and arrhythmias can be a difficult subject to understand. The text below should give you a better understanding of
GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)
AUSTRALIAN RESUSCITATION COUNCIL GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support) The term cardiac arrhythmia
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013
Tachyarrhythmias (fast heart rhythms)
Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout
ARIZONA ARRHYTHMIA CONSULTANTS
Page 1 BUSINESS ADDRESS Arizona Arrhythmia Consultants, PLC Clinical Research Department 7283 East Earl Drive Scottsdale, Arizona 85251 (602) 234-2800 License Adult Nurse Practitioner with Prescriptive
HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)
HTEC 91 Medical Office Diagnostic Tests Week 4 Topic for Today: Atrial Rhythms PACs: Premature Atrial Contractions PAT: Paroxysmal Atrial Tachycardia AF: Atrial Fibrillation Atrial Flutter Premature Atrial
while the incidence of atrial fibrillation
Hellenic J Cardiol 45: 277-281, 2004 Editorial Atrial Fibrillation and Heart Failure PANOS E. VARDAS, HERCULES E. MAVRAKIS Cardiology Department, Heraklion University Hospital, Crete, Greece Key words:
INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES
INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES NOTICE: This is an introductory guide for a user to understand basic ECG tracings and parameters. The guide will allow user to identify some of the
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
CARDIAC ELECTROPHYSIOLOGY, ARRHYTHMIAS AND PACING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational
Know the histology and gross anatomy of the normal sinoatrial node, atrial conduction pathways, atrioventricular (AV) junction and nod, His bundle, conduction fascicles and terminal intra-ventricular conduction
DISCLOSURES. I am a consultant for Biosense Webster St Jude Medical
Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted ICD/CRTD (AATAC-AF in Heart Failure) ClinicalTrials.gov Identifier: NCT00729911/
«Δυσλειτουργία βηματοδότη. Πως μπορούμε να την εκτιμήσουμε στο ιατρείο.» Koσσυβάκης Χάρης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ
«Δυσλειτουργία βηματοδότη. Πως μπορούμε να την εκτιμήσουμε στο ιατρείο.» Koσσυβάκης Χάρης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ Diagnostic tools History: symptoms, physical examination 12 leads ECG,
Introduction. Planned surgical procedures
Guidelines for the perioperative management of patients with implantable pacemakers or implantable cardioverter defibrillators, where the use of surgical diathermy/electrocautery is anticipated. Introduction
1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
Implantable pacemakers and implantable cardioverter
BRIEF REPORT EAS SYSTEMS AND INTERACTIONS WITH IMPLANTABLE CARDIAC DEVICES Electronic Article Surveillance Systems and Interactions With Implantable Cardiac Devices: Risk of Adverse Interactions in Public
Wide-Complex Tachycardias in the ED: Myths and Pitfalls
Wide-Complex Tachycardias in the ED: Myths and Pitfalls, FACEP, FAAEM Professor and Vice Chair Director, Emergency Cardiology Fellowship Department of Emergency Medicine University of Maryland School of
50 years of CRM Device Therapy Past, Present and Future. Richard Sutton Professor of Cardiology Imperial College, London, UK
50 years of CRM Device Therapy Past, Present and Future Richard Sutton Professor of Cardiology Imperial College, London, UK The Past First implant 1958 Sweden Dual Chamber pacing (VAT) 1962 US Transvenous
Inpatient Heart Failure Management: Risks & Benefits
Inpatient Heart Failure Management: Risks & Benefits Dr. Kenneth L. Baughman Professor of Medicine Harvard Medical School Director, Advanced Heart Disease Section Brigham & Women's Hospital Harvard Medical
MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.
Exam Name MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. 1) What term is used to refer to the process of electrical discharge and the flow of electrical
ACLS Defibrillation Protocols With the ZOLL Rectilinear Biphasic Waveform AHA/ERC Guidelines 2005
ACLS Defibrillation Protocols With the ZOLL Rectilinear Biphasic Waveform AHA/ERC Guidelines 2005 Introduction: The purpose of this document is to outline the equivalent biphasic protocols specific to
DH Cardiac Rehabilitation Commissioning Pack: highlights and process. Prof Patrick Doherty BACR conference Liverpool 2010
DH Cardiac Rehabilitation Commissioning Pack: highlights and process Prof Patrick Doherty BACR conference Liverpool 2010 CR commissioning pack working groups: led by SCDU and NHS Improvement 1. A reference
Worldwide Experience with S-ICD: Early results from the EFFORTLESS Registry
Worldwide Experience with S-ICD: Early results from the EFFORTLESS Registry Results published in European Heart Journal (March 2014) Pier D. Lambiase, Craig Barr, Dominic A.M.J. Theuns, Reinoud Knops,
The National Service Framework for Cardiac Disease: Strategic Aims and Implementation A Cardiac Work Programme for Wales
The National Service Framework for Disease: Strategic Aims and A Work Programme for Wales Disease Strategic Framework 2008-11 1 CONTENTS Page 1. Introduction 3 2. Part 1 Strategic Aims 3 3. Part 2 Standard
Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Management of Patients With. Learn and Live SM. ACC/AHA/ESC Pocket Guideline
Learn and Live SM ACC/AHA/ESC Pocket Guideline Based on the ACC/AHA/ESC 2006 Guidelines Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death September 2006 Special
Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter
22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release
UPMC HEALTH PLAN MANAGEMENT OF HEART FAILURE WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: CLINICAL PRACTICE GUIDELINE
General Statement on UPMC Health Plan Clinical Practice Guidelines: UPMC Health Plan develops clinical practice guidelines to support the practice of evidence-based medicine. The guidelines are from recognized
Diagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
Karen Bain James Cook University Hospital Middlesbrough
Karen Bain James Cook University Hospital Middlesbrough Electrophysiology Electrophysiology... Is the study of the heart s electrical system Assesses the function of each component of cardiac conduction
Premature Ventricular Contractions. Ralph Augostini, MD FACC FHRS
Premature Ventricular Contractions Ralph Augostini, MD FACC FHRS Orlando, Florida October 7-9, 2011 Premature Ventricular Contractions: ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular